Related Experiment Video
Updated: Jun 19, 2026

14:15
On-Site Molecular Detection of Soil-Borne Phytopathogens Using a Portable Real-Time PCR System
Published on: February 23, 2018
16.4K
A Rapid Host Response Blood Test for Bacterial/Viral Infection Discrimination Using a Portable Molecular Diagnostic
Maria D Iglesias-Ussel1, Nicholas O'Grady1, Jack Anderson1
1Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Open Forum Infectious Diseases
|January 6, 2025
Summary
A new Biomeme host response (HR-B/V) assay accurately distinguishes bacterial from viral infections using gene expression. This rapid, portable test aids antibiotic stewardship by identifying patients unlikely to have bacterial infections.
Area of Science:
- Infectious Disease
- Molecular Diagnostics
- Genomics
Background:
- Differentiating bacterial from viral infections is challenging, leading to overuse of antibiotics.
- Antibiotic overuse contributes significantly to the development of antimicrobial resistance.
Purpose of the Study:
- To evaluate the performance of a novel host response (HR-B/V) assay for distinguishing bacterial from viral infections.
- To assess the utility of this assay as a diagnostic tool in clinical settings.
Main Methods:
- The study utilized a rapid, portable polymerase chain reaction (PCR)-based test (HR-B/V assay on the Biomeme Franklin platform).
- Three cohorts of patients with suspected infections were tested: a training cohort, a technical correlation cohort, and a COVID-19 cohort.
Main Results:
- The Biomeme HR-B/V test demonstrated high accuracy in discriminating bacterial (84.5%) and viral infections.
- Excellent agreement was observed between the Biomeme HR-B/V test and a previously established BioFire HR-B/V test.
- The test showed high accuracy in identifying bacterial infections in patients with early-stage COVID-19.
Conclusions:
- The Biomeme HR-B/V test is a high-performing, rapid, and portable diagnostic tool.
- This assay shows promise as an antibiotic stewardship strategy for clinical use.
- The test effectively identifies patients unlikely to have bacterial infections, guiding appropriate treatment decisions.
Related Concept Videos
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

